All Stories

  1. Harnessing nature's blueprint: Unlocking the potential of subcellular structure membrane-coated nanosystems for precision medicine
  2. High drug-loaded supramolecular microgels enabled by controlled in-droplet self-assembly for adaptive treatment of inflammatory arthritis
  3. Combating Gram-negative infections: The role of antimicrobial peptides and nanotechnology in overcoming antibiotic resistance
  4. A ratiometric theranostic nanoplatform with acid-triggered drug release and glutathione-activated fluorescence turn-on
  5. Quantum sensing of free radicals in macrophages reveals early autophagy-lysosome regulation in an atherosclerosis cell model
  6. Nanoencapsulated flavonoids for enhanced modulation of the microbiota-gut-brain axis and neurodegenerative add-on therapy
  7. Granular Hydrogels as Modular Biomaterials: From Structural Design to Biological Responses
  8. Outside Front Cover
  9. Programmable Nanostructure Assembly of a Paclitaxel Derivative Enables Tunable Anticancer Therapy via Hydrogen Bond Engineering
  10. Endocytic Programming via Porous Silicon Nanoparticles Enhances TLR4 Nanoagonist Potency for Macrophage‐Mediated Immunotherapy
  11. Wisdom of Crowds for Supporting the Safety Evaluation of Nanomaterials
  12. Organ-on-Chip Platforms for Nanoparticle Toxicity and Efficacy Assessment: Advancing Beyond Traditional In Vitro and In Vivo Models
  13. Metal-organic frameworks in sample preparation for clinical applications – A review
  14. Artificial cells and biomimicry cells: A rising star in the fight against cancer
  15. Probing Early Particle‐Cell Membrane Interactions via Single‐Cell and Single‐Particle Interaction Analysis
  16. Forging a New Frontier: Antimicrobial Peptides and Nanotechnology Converging to Conquer Gastrointestinal Pathogens
  17. Integrated Microfluidic Chip for Neutrophil Extracellular Vesicle Analysis and Gastric Cancer Diagnosis
  18. Transdermal delivery of PeptiCRAd cancer vaccine using microneedle patches
  19. Biological Augmentation Using Electrospun Constructs with Dual Growth Factor Release for Rotator Cuff Repair
  20. Identification of splenic IRF7 as a nanotherapy target for tele-conditioning myocardial reperfusion injury
  21. H2O2‐Generating Advanced Nanomaterials for Cancer Treatment
  22. Engineered Shape-Tunable Copper-Coordinated Nanoparticles for Macrophage Reprogramming
  23. Local glycolysis-modulating hydrogel microspheres for a combined anti-tumor and anti-metastasis strategy through metabolic trapping strategy
  24. Reactive oxygen species switcher via MnO2-coated Prussian blue loaded hyaluronic acid methacrylate hydrogel microspheres for local anti-tumor treatment
  25. Broad-spectrum downregulation of inflammatory cytokines by polydopamine nanoparticles to protect the injured spinal cord
  26. Amniotic epithelial Cell microvesicles uptake inhibits PBMCs and Jurkat cells activation by inducing mitochondria-dependent apoptosis
  27. Effects of LinTT1-peptide conjugation on the properties of poly(ethylene glycol)-block-(ε-caprolactone) nanoparticles prepared by the nanoprecipitation method
  28. Development of Amniotic Epithelial Stem Cells Secretome-Loaded In Situ Inverse Electron Demand Diels–Alder-Cross-Linked Hydrogel as a Potential Immunomodulatory Therapeutical Tool
  29. Hybrid lipid nanoparticles derived from human mesenchymal stem cell extracellular vesicles by microfluidic sonication for collagen I mRNA delivery to human tendon progenitor stem cells
  30. Engineering an oncolytic adenoviral platform for precise delivery of antisense peptide nucleic acid to modulate PD-L1 overexpression in cancer cells
  31. Hijacking plant skeletons for biomedical applications: from regenerative medicine and drug delivery to biosensing
  32. Hybrid Nanoparticles Dual‐Loaded With Curcumin and Benzydamine Hydrochloride for the Treatment of Vulvovaginal Candidiasis: From Development to Biological Application In Vitro and In Vivo (Adv. Therap. 1/2025)
  33. Tailored polysaccharide entrapping metal-organic framework for RNAi therapeutics and diagnostics in atherosclerosis
  34. Preface
  35. Technological Advances and Innovations in the Treatment of Chronic Respiratory Disorders
  36. A Near-Infrared Light Absorbable Hydrogel with Antibacterial Effect for Mild Photothermal Regeneration of Infected Wounds
  37. Polymeric Microspheres with High Mass Fraction of Therapeutics Enabled by the Manipulation of Kinetics Factor During Emulsion Droplet Solidification
  38. A study of the oral bioavailability and biodistribution increase of Nanoencapsulation-driven Delivering radiolabeled anthocyanins
  39. Fabrication of Biomimetic Hybrid Liposomes via Microfluidic Technology: Homotypic Targeting and Antitumor Efficacy Studies in Glioma Cells
  40. Interplay of nano-based delivery systems and protein signalling in ameliorating lung diseases
  41. Cyanocobalamin-loaded dissolving microneedles diminish skin inflammation in vivo
  42. Bioengineered Nanomedicines Targeting the Intestinal Fc Receptor Achieve the Improved Glucoregulatory Effect of Semaglutide in a Type 2 Diabetic Mice Model
  43. Electrochemical detection of atrial natriuretic peptide-coated nanocarriers based on a molecularly imprinted polymer receptor thin film
  44. Hybrid Nanoparticles Dual‐Loaded With Curcumin and Benzydamine Hydrochloride for the Treatment of Vulvovaginal Candidiasis: From Development to Biological Application In Vitro and In Vivo
  45. Nano‐ and Micro‐Platforms in Therapeutic Proteins Delivery for Cancer Therapy: Materials and Strategies
  46. A translational framework to DELIVER nanomedicines to the clinic
  47. Breaking barriers: The potential of nanosystems in antituberculosis therapy
  48. Next-generation chemotherapy treatments based on black hole algorithms: From cancer remission to chronic disease management
  49. Selenium Nanoparticles Synergize with a KRAS Nanovaccine against Breast Cancer
  50. Quantitative analysis of electroporation-mediated intracellular delivery via bioorthogonal luminescent reaction
  51. Unlocking the potential of nanomedicine: advances in precision targeting strategies
  52. Front Cover: Nano Select 7–8 / 2024
  53. Self‐Nanoformulating Poly(2‐oxazoline) and Poly(2‐oxazine) Copolymers Based Amorphous Solid Dispersions as Microneedle Patch: A Formulation Study
  54. Antifibrotic and Pro-regenerative Effects of SMAD3 siRNA and Collagen I mRNA-Loaded Lipid Nanoparticles in Human Tenocytes
  55. Natural compounds-based nanomedicines for cancer treatment: Future directions and challenges
  56. Special Issue on Advances in Porous Materials
  57. Comparative optimization of polysaccharide-based nanoformulations for cardiac RNAi therapy
  58. Implantable Patch of Oxidized Nanofibrillated Cellulose and Lysozyme Amyloid Nanofibrils for the Regeneration of Infarcted Myocardium Tissue and Local Delivery of RNA‐Loaded Nanoparticles
  59. Lipid nanoparticles-based RNA therapies for breast cancer treatment
  60. Self-Nanoformulating Poly(2-oxazoline) and Poly(2-oxazine) Copolymers Based Amorphous Solid Dispersions as Microneedle Patch: A Formulation Study
  61. Curcuma Longa: Nutraceutical Use and Association With Nanotechnology
  62. Advances in Microfluidic‐Based Core@Shell Nanoparticles Fabrication for Cancer Applications
  63. Revolutionizing lung health: Exploring the latest breakthroughs and future prospects of synbiotic nanostructures in lung diseases
  64. Study of the Synergistic Immunomodulatory and Antifibrotic Effects of Dual-Loaded Budesonide and Serpine1 siRNA Lipid–Polymer Nanoparticles Targeting Macrophage Dysregulation in Tendinopathy
  65. In Situ Biofabrication of Microbial Cellulose Capsules Carrying Cubosomes: Toward Colon Targeted Multidrug Delivery
  66. Biomimetic Platelet‐Cloaked Nanoparticles for the Delivery of Anti‐Inflammatory Curcumin in the Treatment of Atherosclerosis
  67. Physicochemical characterization of a lycopene‐loaded mesoporous silica nanoparticle formulation
  68. Cyclosporin A-loaded dissolving microneedles for dermatitis therapy: Development, characterisation and efficacy in a delayed-type hypersensitivity in vivo model
  69. Host-Directed Virus-Mimicking Particles Interacting with the ACE2 Receptor Competitively Block Coronavirus SARS-CoV-2 Entry
  70. New insights into nanomedicines for oral delivery of glucagon‐like peptide‐1 analogs
  71. Engineering and Targeting Neutrophils for Cancer Therapy
  72. Porous Silicon Nanoparticles Conjugated Magnetite‐Chitosan Graphene Oxide Nanoparticles for Effective Removal of Complex Pollutants
  73. Inside Back Cover
  74. Diatom-guided bone healing via a hybrid natural scaffold
  75. Nanoparticles targeting the intestinal Fc receptor enhance intestinal cellular trafficking of semaglutide
  76. Quantum Sensing of Free Radical Generation in Mitochondria of Single Heart Muscle Cells during Hypoxia and Reoxygenation
  77. Porous Si-Based Nanosystems for Immunotherapy Applications
  78. Noninvasive Novel Transdermal Drug Delivery System for Deep Drug Permeability
  79. Cell-based in vitro models for buccal permeability studies
  80. Manganese@Albumin Nanocomplex and Its Assembled Nanowire Activate TLR4‐Dependent Signaling Cascades of Macrophages
  81. Diversity-oriented combinatory formulation screen for cardiac RNAi therapeutics with polysaccharide framework
  82. Polyethylene Glycol‐Stabilized Gold Nanostars‐Loaded Microneedles for Photothermal Therapy of Melanoma
  83. Enhancing Apoptosome Assembly via Mito‐Biomimetic Lipid Nanocarrier for Cancer Therapy (Adv. Funct. Mater. 46/2023)
  84. Emerging applications and prospects of NFκB decoy oligodeoxynucleotides in managing respiratory diseases
  85. Advanced porous materials for antimicrobial treatment
  86. Evaluation of cell membrane-derived nanoparticles as therapeutic carriers for pancreatic ductal adenocarcinoma using an in vitro tumour stroma model
  87. Mycophenolic Acid-loaded Naïve Macrophage-derived Extracellular Vesicles Rescue Cardiac Myoblast after Inflammatory Injury
  88. Acid-labile chemical bonds-based nanoparticles for endosome escape and intracellular delivery
  89. Recent advances in Fenton and Fenton-like reaction mediated nanoparticle in cancer therapy
  90. Emerging strategies to bypass transplant rejection via biomaterial-assisted immunoengineering: Insights from islets and beyond
  91. Development of a time-dependent oral colon delivery system of anaerobic Odoribacter splanchnicus for bacteriotherapy
  92. Macrophage Hitchhiking Nanoparticles for the Treatment of Myocardial Infarction: An In Vitro and In Vivo Study (Adv. Funct. Mater. 34/2023)
  93. Enhancing Apoptosome Assembly via Mito‐Biomimetic Lipid Nanocarrier for Cancer Therapy
  94. Cancer Models on Chip: Paving the Way to Large‐Scale Trial Applications
  95. Development of fast dissolving polymer-based microneedles for delivery of an antigenic melanoma cell membrane
  96. Double‐Layered Polyvinylpyrrolidone–Poly(methyl vinyl ether‐alt‐maleic acid)‐Based Microneedles to Deliver Meloxicam: An In Vitro, In Vivo, and Short‐Term Stability Evaluation Study
  97. In Vitro Characterization and Real-Time Label-Free Assessment of the Interaction of Chitosan-Coated Niosomes with Intestinal Cellular Monolayers
  98. Fabricated technology of biomedical micro-nano hydrogel
  99. Multifunctional nanostructures: Intelligent design to overcome biological barriers
  100. Development of siRNA and Budesonide Dual‐Loaded Hybrid Lipid–Polymer Nanoparticles by Microfluidics Technology as a Platform for Dual Drug Delivery to Macrophages: An In Vitro Mechanistic Study
  101. Macrophage Hitchhiking Nanoparticles for the Treatment of Myocardial Infarction: An In Vitro and In Vivo Study
  102. Injectable Nanocomposite Hydrogels of Gelatin-Hyaluronic Acid Reinforced with Hybrid Lysozyme Nanofibrils-Gold Nanoparticles for the Regeneration of Damaged Myocardium
  103. In Vitro Study of the Anti-inflammatory and Antifibrotic Activity of Tannic Acid-Coated Curcumin-Loaded Nanoparticles in Human Tenocytes
  104. Nanoparticles-based phototherapy systems for cancer treatment: Current status and clinical potential
  105. Rational design of a polysaccharide-based viral mimicry nanocomplex for potent gene silencing in inflammatory tissues
  106. Controlled Interfacial Polymer Self‐Assembly Coordinates Ultrahigh Drug Loading and Zero‐Order Release in Particles Prepared under Continuous Flow
  107. A photoactive injectable antibacterial hydrogel to support chemo-immunotherapeutic effect of antigenic cell membrane and sorafenib by near-infrared light mediated tumor ablation
  108. Microfluidic preparation and optimization of sorafenib-loaded poly(ethylene glycol-block-caprolactone) nanoparticles for cancer therapy applications
  109. Nanostructured multifunctional stimuli-responsive glycopolypeptide-based copolymers for biomedical applications
  110. Porous Silicon Nanocarriers Boost the Immunomodulation of Mitochondria-Targeted Bovine Serum Albumins on Macrophage Polarization
  111. Recent approaches for enhancing the performance of dissolving microneedles in drug delivery applications
  112. Introduction to the RSC Advances themed collection on Nanomaterials in drug delivery
  113. Microfluidic‐Assisted Production of Gastro‐Resistant Active‐Targeted Diatomite Nanoparticles for the Local Release of Galunisertib in Metastatic Colorectal Cancer Cells (Adv. Healthcare Mater. 6/2023)
  114. Microfluidics as a Tool for the Synthesis of Advanced Drug Delivery Systems
  115. Fabrication of hydrogel microspheres via microfluidics using inverse electron demand Diels–Alder click chemistry-based tetrazine-norbornene for drug delivery and cell encapsulation applications
  116. Smart Nanoparticle‐based Platforms for Regulating Tumor Microenvironment and Cancer Immunotherapy
  117. Microfluidic‐Assisted Production of Gastro‐Resistant Active‐Targeted Diatomite Nanoparticles for the Local Release of Galunisertib in Metastatic Colorectal Cancer Cells
  118. A pH‐Responsive Cluster Metal–Organic Framework Nanoparticle for Enhanced Tumor Accumulation and Antitumor Effect (Adv. Mater. 42/2022)
  119. A pH‐Responsive Cluster Metal–Organic Framework Nanoparticle for Enhanced Tumor Accumulation and Antitumor Effect
  120. Development of Surface Chemical Strategies for Synthesizing Redox‐Responsive Diatomite Nanoparticles as a Green Platform for On‐Demand Intracellular Release of an Antisense Peptide Nucleic Acid Anticancer Agent
  121. Promoting Cardiac Repair through Simple Engineering of Nanoparticles with Exclusive Targeting Capability toward Myocardial Reperfusion Injury by Thermal Resistant Microfluidic Platform (Adv. Funct. Mater. 36/2022)
  122. Folic acid-mesoporous silicon nanoparticles enhance the anticancer activity of the p73-activating small molecule LEM2
  123. Promoting Cardiac Repair through Simple Engineering of Nanoparticles with Exclusive Targeting Capability toward Myocardial Reperfusion Injury by Thermal Resistant Microfluidic Platform
  124. Microfluidics fabrication of micrometer‐sized hydrogels with precisely controlled geometries for biomedical applications
  125. Current trends in delivery of non-viral nucleic acid-based therapeutics for improved efficacy
  126. Autologous Skin Fibroblast‐Based PLGA Nanoparticles for Treating Multiorgan Fibrosis
  127. Molecular scale study on the interactions of biocompatible nanoparticles with macrophage membrane and blood proteins
  128. Mussel-Inspired and Bioclickable Peptide Engineered Surface to Combat Thrombosis and Infection
  129. Inhaled hydrogel-based microspheres for management of COVID-19: A new sweeper biological platform
  130. Progress in Stimuli‐Responsive Biomaterials for Treating Cardiovascular and Cerebrovascular Diseases
  131. Artificial Intelligence Deep Exploration of Influential Parameters on Physicochemical Properties of Curcumin‐Loaded Electrospun Nanofibers
  132. High drug-loaded microspheres enabled by controlled in-droplet precipitation promote functional recovery after spinal cord injury
  133. Functional biomaterials
  134. Neonatal Fc receptor-targeted lignin-encapsulated porous silicon nanoparticles for enhanced cellular interactions and insulin permeation across the intestinal epithelium
  135. Biomimetic platelet membrane-coated nanoparticles for targeted therapy
  136. Multifunctional Biomimetic Nanovaccines Based on Photothermal and Weak‐Immunostimulatory Nanoparticulate Cores for the Immunotherapy of Solid Tumors (Adv. Mater. 9/2022)
  137. Surface Adsorption‐Mediated Ultrahigh Efficient Peptide Encapsulation with a Precise Ratiometric Control for Type 1 and 2 Diabetic Therapy
  138. Gelatin‐Lysozyme Nanofibrils Electrospun Patches with Improved Mechanical, Antioxidant and Bioresorbability Properties for Myocardial Regeneration Applications
  139. Multifunctional Biomimetic Nanovaccines Based on Photothermal and Weak‐Immunostimulatory Nanoparticulate Cores for the Immunotherapy of Solid Tumors
  140. Engineered neutrophil-derived exosome-like vesicles for targeted cancer therapy
  141. Scaffold Vaccines for Generating Robust and Tunable Antibody Responses
  142. Synergistic immunomodulatory effect in macrophages mediated by magnetic nanoparticles modified with miRNAs
  143. Microfluidic preparation and in vitro evaluation of iRGD-functionalized solid lipid nanoparticles for targeted delivery of paclitaxel to tumor cells
  144. Emerging Theranostic Nanomaterials in Diabetes and Its Complications
  145. Tendon Tissue Repair in Prospective of Drug Delivery, Regenerative Medicines, and Innovative Bioscaffolds
  146. Inhibiting Phase Transfer of Protein Nanoparticles by Surface Camouflage–A Versatile and Efficient Protein Encapsulation Strategy
  147. In Vitro Evaluation of the Therapeutic Effects of Dual‐Drug Loaded Spermine‐Acetalated Dextran Nanoparticles Coated with Tannic Acid for Cardiac Applications
  148. Prospective Cancer Therapies Using Stimuli‐Responsive DNA Nanostructures
  149. Dual‐Crosslinked Dynamic Hydrogel Incorporating {Mo 154 } with pH and NIR Responsiveness for Chemo‐Photothermal Therapy (Adv. Mater. 40/2021)
  150. Peptide-guided resiquimod-loaded lignin nanoparticles convert tumor-associated macrophages from M2 to M1 phenotype for enhanced chemotherapy
  151. Programmable immune activating electrospun fibers for skin regeneration
  152. Nonresonant CARS Imaging of Porous and Solid Silicon Nanoparticles in Human Cells
  153. Engineering of 2D nanomaterials to trap and kill SARS-CoV-2: a new insight from multi-microsecond atomistic simulations
  154. Dual‐Crosslinked Dynamic Hydrogel Incorporating {Mo 154 } with pH and NIR Responsiveness for Chemo‐Photothermal Therapy
  155. Prevention of diabetes-associated fibrosis: Strategies in FcRn-targeted nanosystems for oral drug delivery
  156. Quantitative Analysis of Porous Silicon Nanoparticles Functionalization by 1H NMR
  157. Engineering of 2D Materials To Trap And Kill SARS-CoV-2: A New Insight From Multi-Microsecond Atomistic Simulations
  158. Light‐Controlled Nanosystems: Light‐Controlled Nanosystem with Size‐Flexibility Improves Targeted Retention for Tumor Suppression (Adv. Funct. Mater. 27/2021)
  159. Non-viral nanoparticles for RNA interference: Principles of design and practical guidelines
  160. Selenium Nanoparticles for Biomedical Applications: From Development and Characterization to Therapeutics
  161. Multistage signal-interactive nanoparticles improve tumor targeting through efficient nanoparticle-cell communications
  162. An organic-inorganic hybrid scaffold with honeycomb-like structures enabled by one-step self-assembly-driven electrospinning
  163. Light‐Controlled Nanosystem with Size‐Flexibility Improves Targeted Retention for Tumor Suppression
  164. A Theranostic Cellulose Nanocrystal‐Based Drug Delivery System with Enhanced Retention in Pulmonary Metastasis of Melanoma
  165. Mitochondria‐Targeted Bovine Serum Albumin@Copper Sulfide Nanocomposites Conjugated with Rhodamine‐110 Dye for an Enhanced Efficacy of Cancer Photothermal Therapy
  166. Chemically Engineered Immune Cell‐Derived Microrobots and Biomimetic Nanoparticles: Emerging Biodiagnostic and Therapeutic Tools
  167. DNA‐Grafted Hyaluronic Acid System with Enhanced Injectability and Biostability for Photo‐Controlled Osteoarthritis Gene Therapy
  168. LinTT1 peptide-functionalized liposomes for targeted breast cancer therapy
  169. Synthesis and therapeutic potential of stimuli-responsive metal-organic frameworks
  170. One-step microfluidics production of enzyme-loaded liposomes for the treatment of inflammatory diseases
  171. Engineered Extracellular Vesicles for Cancer Therapy
  172. Development of vaccine formulations: past, present, and future
  173. Nanoparticle‐mediated siRNA delivery systems for cancer therapy
  174. Microneedles for painless transdermal immunotherapeutic applications
  175. Anti‐Bacterial Hydrogels: A Hydrogen‐Bonded Extracellular Matrix‐Mimicking Bactericidal Hydrogel with Radical Scavenging and Hemostatic Function for pH‐Responsive Wound Healing Acceleration (Adv. Healthcare Mater. 3/2021)
  176. Intraoperative Assessment and Photothermal Ablation of the Tumor Margins Using Gold Nanoparticles
  177. Correction: Acetalated dextran based nano- and microparticles: synthesis, fabrication, and therapeutic applications
  178. Front cover
  179. Advanced Nanosystems for Clinical Translation
  180. Investigation of silicon nanoparticles produced by centrifuge chemical vapor deposition for applications in therapy and diagnostics
  181. Acetalated dextran based nano- and microparticles: synthesis, fabrication, and therapeutic applications
  182. Biohybrid Nanosystems for Cancer Treatment: Merging the Best of Two Worlds
  183. Conventional Nanosized Drug Delivery Systems for Cancer Applications
  184. Front Matter
  185. Introduction to lignocellulosic materials
  186. Requirements and properties of biomaterials for biomedical applications
  187. Bio-Nanomedicine for Cancer Therapy
  188. Porous Silicon for Biomedical Applications
  189. Combination Therapy of Killing Diseases by Injectable Hydrogels: From Concept to Medical Applications
  190. Preparation of cetyl palmitate-based PEGylated solid lipid nanoparticles by microfluidic technique
  191. Evaluation of the effects of nanoprecipitation process parameters on the size and morphology of poly(ethylene oxide)-block-polycaprolactone nanostructures
  192. Recent progress in the design of DNA vaccines against tuberculosis
  193. Cell–Nanoparticle Interactions: Toxicity and Safety Issues
  194. A Hydrogen‐Bonded Extracellular Matrix‐Mimicking Bactericidal Hydrogel with Radical Scavenging and Hemostatic Function for pH‐Responsive Wound Healing Acceleration
  195. One‐Pot Synthesis of pH‐Responsive Eudragit‐Mesoporous Silica Nanocomposites Enable Colonic Delivery of Glucocorticoids for the Treatment of Inflammatory Bowel Disease
  196. Requirements for Animal Experiments: Problems and Challenges
  197. Emerging insights on drug delivery by fatty acid mediated synthesis of lipophilic prodrugs as novel nanomedicines
  198. 3D scaffolding of fast photocurable polyurethane for soft tissue engineering by stereolithography: Influence of materials and geometry on growth of fibroblast cells
  199. Recombination Monophosphoryl Lipid A-Derived Vacosome for the Development of Preventive Cancer Vaccines
  200. Cell Membrane Wrapping: Influence of Cell Membrane Wrapping on the Cell−Porous Silicon Nanoparticle Interactions (Adv. Healthcare Mater. 17/2020)
  201. Formulation optimization and in vitro characterization of rifampicin and ceftriaxone dual drug loaded niosomes with high energy probe sonication technique
  202. Influence of Cell Membrane Wrapping on the Cell−Porous Silicon Nanoparticle Interactions
  203. Colorectal cancer triple co-culture spheroid model to assess the biocompatibility and anticancer properties of polymeric nanoparticles
  204. Multifunctional 3D‐Printed Patches for Long‐Term Drug Release Therapies after Myocardial Infarction
  205. Tandem‐Mass‐Tag Based Proteomic Analysis Facilitates Analyzing Critical Factors of Porous Silicon Nanoparticles in Determining Their Biological Responses under Diseased Condition
  206. Intracellular Delivery of Budesonide and Polydopamine Co‐Loaded in Endosomolytic Poly(butyl methacrylate‐ co ‐methacrylic acid) Grafted Acetalated Dextran for Macrophage Phenotype Switch from M1 to M2
  207. The Progress and Prospect of Zeolitic Imidazolate Frameworks in Cancer Therapy, Antibacterial Activity, and Biomineralization
  208. Microfluidic fabrication and characterization of Sorafenib-loaded lipid-polymer hybrid nanoparticles for controlled drug delivery
  209. Microvascular Scaffolds: A Biomimetic 3D‐Self‐Forming Approach for Microvascular Scaffolds (Adv. Sci. 9/2020)
  210. Preparation and in vivo evaluation of red blood cell membrane coated porous silicon nanoparticles implanted with 155Tb
  211. Polyoxometalate Composites in Cancer Therapy and Diagnostics
  212. The solid progress of nanomedicine
  213. A Biomimetic 3D‐Self‐Forming Approach for Microvascular Scaffolds
  214. Microfluidics: Microfluidics for Production of Particles: Mechanism, Methodology, and Applications (Small 9/2020)
  215. Gold–silver nanoshells promote wound healing from drug-resistant bacteria infection and enable monitoring via surface-enhanced Raman scattering imaging
  216. Recent trends on the development of systems for cancer diagnosis and treatment by microfluidic technology
  217. Immunogenicity of Polyethylene Glycol Based Nanomedicines: Mechanisms, Clinical Implications and Systematic Approach
  218. Lipid-Polymer Hybrid Nanoparticles for Controlled Delivery of Hydrophilic and Lipophilic Doxorubicin for Breast Cancer Therapy [Erratum]
  219. Advanced liposome-loaded scaffolds for therapeutic and tissue engineering applications
  220. Fabrication and Characterization of Drug-Loaded Conductive Poly(glycerol sebacate)/Nanoparticle-Based Composite Patch for Myocardial Infarction Applications
  221. Design, synthesis and characterization of a PEGylated stanozolol for potential therapeutic applications
  222. Near-infrared light and magnetic field dual-responsive porous silicon-based nanocarriers to overcome multidrug resistance in breast cancer cells with enhanced efficiency
  223. Engineered antibody-functionalized porous silicon nanoparticles for therapeutic targeting of pro-survival pathway in endogenous neuroblasts after stroke
  224. Dual-peptide functionalized acetalated dextran-based nanoparticles for sequential targeting of macrophages during myocardial infarction
  225. The versatile biomedical applications of bismuth-based nanoparticles and composites: therapeutic, diagnostic, biosensing, and regenerative properties
  226. Microfibers synthesized by wet-spinning of chitin nanomaterials: mechanical, structural and cell proliferation properties
  227. New insights into ethionamide metabolism: influence of oxidized methionine on its degradation path
  228. Hybrid red blood cell membrane coated porous silicon nanoparticles functionalized with cancer antigen induce depletion of T cells
  229. Novel RET agonist for the treatment of experimental neuropathies
  230. Oral drug delivery: Overview
  231. Spray-drying for the formulation of oral drug delivery systems
  232. All-in-one microfluidic assembly of insulin-loaded pH-responsive nano-in-microparticles for oral insulin delivery
  233. Mild temperature photothermal assisted anti-bacterial and anti-inflammatory nanosystem for synergistic treatment of post-cataract surgery endophthalmitis
  234. Superfast and controllable microfluidic inking of anti-inflammatory melanin-like nanoparticles inspired by cephalopods
  235. Gene‐Hydrogel Microenvironments: Gene‐Hydrogel Microenvironment Regulates Extracellular Matrix Metabolism Balance in Nucleus Pulposus (Adv. Sci. 1/2020)
  236. Osteogenic Hydrogels: Gelatin Templated Polypeptide Co‐Cross‐Linked Hydrogel for Bone Regeneration (Adv. Healthcare Mater. 1/2020)
  237. Cover Image
  238. Nanotechnology for Oral Drug Delivery
  239. Nanomedicine Therapies
  240. Handbook of In Vivo Chemistry in Mice
  241. Systematic in vitro biocompatibility studies of multimodal cellulose nanocrystal and lignin nanoparticles
  242. Gelatin Templated Polypeptide Co‐Cross‐Linked Hydrogel for Bone Regeneration
  243. Artificially cloaked viral nanovaccine for cancer immunotherapy
  244. Utilization of green formulation technique and efficacy estimation on cell line studies for dual anticancer drug therapy with niosomes
  245. Antitumor Therapeutics: A Virus‐Mimicking pH‐Responsive Acetalated Dextran‐Based Membrane‐Active Polymeric Nanoparticle for Intracellular Delivery of Antitumor Therapeutics (Adv. Funct. Mater. 51/2019)
  246. Functionalized Bacterial Cellulose Microparticles for Drug Delivery in Biomedical Applications
  247. Reactive oxygen species responsive nanoplatforms as smart drug delivery systems for gastrointestinal tract targeting
  248. Microfluidics for Production of Particles: Mechanism, Methodology, and Applications
  249. Gene‐Hydrogel Microenvironment Regulates Extracellular Matrix Metabolism Balance in Nucleus Pulposus
  250. A Virus‐Mimicking pH‐Responsive Acetalated Dextran‐Based Membrane‐Active Polymeric Nanoparticle for Intracellular Delivery of Antitumor Therapeutics
  251. Latest Advances on Bacterial Cellulose‐Based Materials for Wound Healing, Delivery Systems, and Tissue Engineering
  252. Landing a lethal blow on bacterial infections: an emerging advance of nanodots for wound healing acceleration
  253. Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy
  254. Antimicrobial Colloidal Silver–Lignin Particles via Ion and Solvent Exchange
  255. Metal Species–Encapsulated Mesoporous Silica Nanoparticles: Current Advancements and Latest Breakthroughs
  256. Publisher Correction: On the issue of transparency and reproducibility in nanomedicine
  257. Publisher Correction: On the issue of transparency and reproducibility in nanomedicine
  258. Lipid-polymer hybrid nanoparticles for controlled delivery of hydrophilic and lipophilic doxorubicin for breast cancer therapy
  259. On the issue of transparency and reproducibility in nanomedicine
  260. Self-Healing and Injectable Hydrogel for Matching Skin Flap Regeneration
  261. Acetalated Dextran Nanoparticles Loaded into an Injectable Alginate Cryogel for Combined Chemotherapy and Cancer Vaccination
  262. Microfluidics: Nuts and Bolts: Microfluidics for the Production of Biomaterials (Adv. Mater. Technol. 6/2019)
  263. Acetylated Nanocellulose for Single-Component Bioinks and Cell Proliferation on 3D-Printed Scaffolds
  264. Biohybrid Vaccines for Improved Treatment of Aggressive Melanoma with Checkpoint Inhibitor
  265. Preparation and Characterization of Dentin Phosphophoryn‐Derived Peptide‐Functionalized Lignin Nanoparticles for Enhanced Cellular Uptake
  266. Using microfluidic platforms to develop CNS-targeted polymeric nanoparticles for HIV therapy
  267. Automatic methodologies to perform loading and release assays of anticancer drugs from mesoporous silicon nanoparticles
  268. Process optimization of ecological probe sonication technique for production of rifampicin loaded niosomes
  269. Photothermal-responsive nanosized hybrid polymersome as versatile therapeutics codelivery nanovehicle for effective tumor suppression
  270. Correction to “Targeted Reinforcement of Macrophage Reprogramming Toward M2 Polarization by IL-4-Loaded Hyaluronic Acid Particles”
  271. Porous Silicon as a Platform for Radiation Theranostics Together with a Novel RIB-Based Radiolanthanoid
  272. Self‐Healing: Self‐Healing and Injectable Hydrogel for Matching Skin Flap Regeneration (Adv. Sci. 3/2019)
  273. Metal-Based Stents: Endovascular Metal Devices for the Treatment of Cerebrovascular Diseases (Adv. Mater. 8/2019)
  274. Nuts and Bolts: Microfluidics for the Production of Biomaterials
  275. Laser-Activatable CuS Nanodots to Treat Multidrug-Resistant Bacteria and Release Copper Ion to Accelerate Healing of Infected Chronic Nonhealing Wounds
  276. Outer–inner dual reinforced micro/nano hierarchical scaffolds for promoting osteogenesis
  277. Advanced Nanovaccines for Immunotherapy Applications: From Concept to Animal Tests
  278. Close-loop dynamic nanohybrids on collagen-ark with in situ gelling transformation capability for biomimetic stage-specific diabetic wound healing
  279. Microfluidic mixing and devices for preparing nanoparticulate drug delivery systems
  280. Photosensitive materials for constructing on-demanded drug-release systems
  281. Targeted Reinforcement of Macrophage Reprogramming Toward M2 Polarization by IL-4-Loaded Hyaluronic Acid Particles
  282. Endovascular Metal Devices for the Treatment of Cerebrovascular Diseases
  283. Microfluidic Nanoassembly of Bioengineered Chitosan-Modified FcRn-Targeted Porous Silicon Nanoparticles @ Hypromellose Acetate Succinate for Oral Delivery of Antidiabetic Peptides
  284. Euryale Ferox Seed-Inspired Superlubricated Nanoparticles for Treatment of Osteoarthritis
  285. Adjustable hardness of hydrogel for promoting vascularization and maintaining stemness of stem cells in skin flap regeneration
  286. Hierarchical structured and programmed vehicles deliver drugs locally to inflamed sites of intestine
  287. Cellular Internalization-Induced Aggregation of Porous Silicon Nanoparticles for Ultrasound Imaging and Protein-Mediated Protection of Stem Cells
  288. Electrospun Fibrous Architectures for Drug Delivery, Tissue Engineering and Cancer Therapy
  289. Cell‐Nanoparticle Interactions at (Sub)–Nanometer Resolution Analyzed by Electron Microscopy and Correlative Coherent Anti‐Stokes Raman Scattering
  290. Self‐Healing and Injectable Hydrogel for Matching Skin Flap Regeneration
  291. Radiolabeled Molecular Imaging Probes for the In Vivo Evaluation of Cellulose Nanocrystals for Biomedical Applications
  292. pH and Reactive Oxygen Species‐Sequential Responsive Nano‐in‐Micro Composite for Targeted Therapy of Inflammatory Bowel Disease
  293. Localized Controlled Delivery of Gemcitabine via Microsol Electrospun Fibers to Prevent Pancreatic Cancer Recurrence
  294. GDNF mimetics delivery by porous silicon nanoparticles for improved Parkinson’s disease management
  295. DNA Hydrogel Assemblies: Bridging Synthesis Principles to Biomedical Applications
  296. Light-Activatable Assembled Nanoparticles to Improve Tumor Penetration and Eradicate Metastasis in Triple Negative Breast Cancer
  297. Impact of Pore Size and Surface Chemistry of Porous Silicon Particles and Structure of Phospholipids on Their Interactions
  298. Materials Science in Finland
  299. Production of pure drug nanocrystals and nano co-crystals by confinement methods
  300. Materials Science in Finland: (Adv. Mater. 24/2018)
  301. Engineered Multifunctional Albumin-Decorated Porous Silicon Nanoparticles for FcRn Translocation of Insulin
  302. Mesoporous Silica Nanoparticles for Targeted and Stimuli-Responsive Delivery of Chemotherapeutics: A Review
  303. Sequential Antifouling Surface for Efficient Modulation of the Nanoparticle-Cell Interactions in Protein-Rich Environments
  304. Bioengineered Porous Silicon Nanoparticles@Macrophages Cell Membrane as Composite Platforms for Rheumatoid Arthritis
  305. Electrospun Polyhydroxybutyrate/Poly(ε-caprolactone)/Sol–Gel-Derived Silica Hybrid Scaffolds with Drug Releasing Function for Bone Tissue Engineering Applications
  306. Properties and chemical modifications of lignin: Towards lignin-based nanomaterials for biomedical applications
  307. Neuroprotection: Biodegradable Spheres Protect Traumatically Injured Spinal Cord by Alleviating the Glutamate-Induced Excitotoxicity (Adv. Mater. 14/2018)
  308. Immunostimulation and Immunosuppression: Nanotechnology on the Brink
  309. Cardiac Actions of a Small Molecule Inhibitor Targeting GATA4–NKX2-5 Interaction
  310. Tailoring Porous Silicon for Biomedical Applications: From Drug Delivery to Cancer Immunotherapy
  311. The importance of microfluidics for the preparation of nanoparticles as advanced drug delivery systems
  312. Current developments and applications of microfluidic technology toward clinical translation of nanomedicines
  313. Cell Membrane-Based Nanoreactor To Mimic the Bio-Compartmentalization Strategy of a Cell
  314. Biodegradable Spheres Protect Traumatically Injured Spinal Cord by Alleviating the Glutamate-Induced Excitotoxicity
  315. Gold Nanorods Conjugated Porous Silicon Nanoparticles Encapsulated in Calcium Alginate Nano Hydrogels Using Microemulsion Templates
  316. Dual-Drug Delivery Using Dextran-Functionalized Nanoparticles Targeting Cardiac Fibroblasts for Cellular Reprogramming
  317. An immunological electrospun scaffold for tumor cell killing and healthy tissue regeneration
  318. Biofunctionalized Mesoporous Silica Nanomaterials for Targeted Drug Delivery
  319. Conductive vancomycin-loaded mesoporous silica polypyrrole-based scaffolds for bone regeneration
  320. The Emerging Role of Multifunctional Theranostic Materials in Cancer Nanomedicine
  321. 3D printing: prospects and challenges
  322. Functionalization of carboxylated lignin nanoparticles for targeted and pH-responsive delivery of anticancer drugs
  323. Development and optimization of methotrexate-loaded lipid-polymer hybrid nanoparticles for controlled drug delivery applications
  324. Cancer Therapy: Nutlin‐3a and Cytokine Co‐loaded Spermine‐Modified Acetalated Dextran Nanoparticles for Cancer Chemo‐Immunotherapy (Adv. Funct. Mater. 42/2017)
  325. Manipulating Superparamagnetic Microparticles with an Electromagnetic Needle
  326. Multifunctional Nanohybrid Based on Porous Silicon Nanoparticles, Gold Nanoparticles, and Acetalated Dextran for Liver Regeneration and Acute Liver Failure Theranostics
  327. Fabrication of Calcium Phosphate-Based Nanocomposites Incorporating DNA Origami, Gold Nanorods, and Anticancer Drugs for Biomedical Applications
  328. Nutlin-3a and Cytokine Co-loaded Spermine-Modified Acetalated Dextran Nanoparticles for Cancer Chemo-Immunotherapy
  329. Non-invasive strategies for targeting the posterior segment of eye
  330. Functionalized materials for multistage platforms in the oral delivery of biopharmaceuticals
  331. Protein Coating of DNA Nanostructures for Enhanced Stability and Immunocompatibility
  332. Drug-Loaded Multifunctional Nanoparticles Targeted to the Endocardial Layer of the Injured Heart Modulate Hypertrophic Signaling
  333. Multifunctional Nanotube-Mucoadhesive Poly(methyl vinyl ether-co -maleic acid)@Hydroxypropyl Methylcellulose Acetate Succinate Composite for Site-Specific Oral Drug Delivery
  334. Photoluminescent Hybrids of Cellulose Nanocrystals and Carbon Quantum Dots as Cytocompatible Probes for in Vitro Bioimaging
  335. Coating Nanoparticles with Plant-Produced Transferrin–Hydrophobin Fusion Protein Enhances Their Uptake in Cancer Cells
  336. A multifunctional nanocomplex for enhanced cell uptake, endosomal escape and improved cancer therapeutic effect
  337. Surface modification of acetaminophen particles by atomic layer deposition
  338. The impact of porous silicon nanoparticles on human cytochrome P450 metabolism in human liver microsomes in vitro
  339. Bridging the Knowledge of Different Worlds to Understand the Big Picture of Cancer Nanomedicines
  340. Insights into Caco-2 cell culture structure using coherent anti-Stokes Raman scattering (CARS) microscopy
  341. A Versatile Carbonic Anhydrase IX Targeting Ligand-Functionalized Porous Silicon Nanoplatform for Dual Hypoxia Cancer Therapy and Imaging
  342. Microfluidic Encapsulation of Prickly Zinc-Doped Copper Oxide Nanoparticles with VD1142 Modified Spermine Acetalated Dextran for Efficient Cancer Therapy
  343. Receptor-Mediated Surface Charge Inversion Platform Based on Porous Silicon Nanoparticles for Efficient Cancer Cell Recognition and Combination Therapy
  344. Intracellular responsive dual delivery by endosomolytic polyplexes carrying DNA anchored porous silicon nanoparticles
  345. Nanoreactors: Biomimetic Engineering Using Cancer Cell Membranes for Designing Compartmentalized Nanoreactors with Organelle-Like Functions (Adv. Mater. 11/2017)
  346. Drug Delivery: A Nano-in-Nano Vector: Merging the Best of Polymeric Nanoparticles and Drug Nanocrystals (Adv. Funct. Mater. 9/2017)
  347. In vitro evaluation of biodegradable lignin-based nanoparticles for drug delivery and enhanced antiproliferation effect in cancer cells
  348. Preparation and biological evaluation of ethionamide-mesoporous silicon nanoparticles against Mycobacterium tuberculosis
  349. Nanovaccines: Multistaged Nanovaccines Based on Porous Silicon@Acetalated Dextran@Cancer Cell Membrane for Cancer Immunotherapy (Adv. Mater. 7/2017)
  350. Fabrication, characterization and evaluation of bacterial cellulose-based capsule shells for oral drug delivery
  351. Biomimetic Engineering Using Cancer Cell Membranes for Designing Compartmentalized Nanoreactors with Organelle-Like Functions
  352. A Nano-in-Nano Vector: Merging the Best of Polymeric Nanoparticles and Drug Nanocrystals
  353. Core/Shell Nanocomposites Produced by Superfast Sequential Microfluidic Nanoprecipitation
  354. Cell Scaffolds: Electrospun Photocrosslinkable Hydrogel Fibrous Scaffolds for Rapid In Vivo Vascularized Skin Flap Regeneration (Adv. Funct. Mater. 2/2017)
  355. Microfluidic assembly of a nano-in-micro dual drug delivery platform composed of halloysite nanotubes and a pH-responsive polymer for colon cancer therapy
  356. Microfluidic-assisted fabrication of carriers for controlled drug delivery
  357. Microfluidics platform for glass capillaries and its application in droplet and nanoparticle fabrication
  358. Springer Handbook of Nanotechnology
  359. Nano-Particles for Biomedical Applications
  360. Inside Cover Image, Volume 9, Issue 1
  361. Multistaged Nanovaccines Based on Porous Silicon@Acetalated Dextran@Cancer Cell Membrane for Cancer Immunotherapy
  362. Quercetin-Based Modified Porous Silicon Nanoparticles for Enhanced Inhibition of Doxorubicin-Resistant Cancer Cells
  363. Drug Delivery: Gold Nanorods, DNA Origami, and Porous Silicon Nanoparticle-functionalized Biocompatible Double Emulsion for Versatile Targeted Therapeutics and Antibody Combination Therapy (Adv. Mater. 46/2016)
  364. Microparticles to enhance delivery of drugs and growth factors into wound sites
  365. Active diffusion of nanoparticles of maternal origin within the embryonic brain
  366. Advances in biomedical and pharmaceutical applications of functional bacterial cellulose-based nanocomposites
  367. Gold Nanorods, DNA Origami, and Porous Silicon Nanoparticle‐functionalized Biocompatible Double Emulsion for Versatile Targeted Therapeutics and Antibody Combination Therapy
  368. Enhanced Photoluminescence in Acetylene-Treated ZnO Nanorods
  369. Angiopep2-functionalized polymersomes for targeted doxorubicin delivery to glioblastoma cells
  370. Microfluidics as a cutting-edge technique for drug delivery applications
  371. Targeted Cancer Therapy: pH-Switch Nanoprecipitation of Polymeric Nanoparticles for Multimodal Cancer Targeting and Intracellular Triggered Delivery of Doxorubicin (Adv. Healthcare Mater. 15/2016)
  372. Delivery of therapeutics with nanoparticles: what's new in cancer immunotherapy?
  373. Antiproliferative Activity and Cellular Uptake of Evodiamine and Rutaecarpine Based on 3D Tumor Models
  374. In vitro and in vivo assessment of heart-homing porous silicon nanoparticles
  375. Silica-Based Nanovectors: From Mother Nature to Biomedical Applications
  376. Applications of bacterial cellulose in food, cosmetics and drug delivery
  377. pH-Switch Nanoprecipitation of Polymeric Nanoparticles for Multimodal Cancer Targeting and Intracellular Triggered Delivery of Doxorubicin
  378. Oral hypoglycaemic effect of GLP-1 and DPP4 inhibitor based nanocomposites in a diabetic animal model
  379. Dual chitosan/albumin-coated alginate/dextran sulfate nanoparticles for enhanced oral delivery of insulin
  380. A comprehensive review of the neonatal Fc receptor and its application in drug delivery
  381. An In Situ Gelling Drug Delivery System for Improved Recovery after Spinal Cord Injury
  382. Neovascularization: Upregulating Hif-1α by Hydrogel Nanofibrous Scaffolds for Rapidly Recruiting Angiogenesis Relative Cells in Diabetic Wound (Adv. Healthcare Mater. 8/2016)
  383. Upregulating Hif-1α by Hydrogel Nanofibrous Scaffolds for Rapidly Recruiting Angiogenesis Relative Cells in Diabetic Wound
  384. Functionalized nanoparticles for targeting the gastrointestinal apical membrane receptors
  385. Mesoporous Biomaterials: a Lexicon and Structured Bibliography of Reviews
  386. Chemotherapy with Porous Silicon
  387. In vivo dual-delivery of glucagon like peptide-1 (GLP-1) and dipeptidyl peptidase-4 (DPP4) inhibitor through composites prepared by microfluidics for diabetes therapy
  388. Corrigendum to “Polymer-based nanoparticles for oral insulin delivery: Revisited approaches”,[Biotechnol Adv. 2015 Nov 1;33 (6 Pt 3):1342–54]
  389. Opinion Paper: Microfluidics Technique to Revolutionize the Drug Delivery Field: Current Developments and Applications
  390. Copolymers: Drug Delivery
  391. Controlled Shape and Nucleation Switching of Interfacially Polymerizable Nanoassemblies by Methyl Substitution
  392. Advanced Nanomedicines for the Treatment and Diagnosis of Myocardial Infarction and Heart Failure
  393. Multistage pH-responsive mucoadhesive nanocarriers prepared by aerosol flow reactor technology: A controlled dual protein-drug delivery system
  394. Polymer-based nanoparticles for oral insulin delivery: Revisited approaches
  395. Cyclodextrin-Modified Porous Silicon Nanoparticles for Efficient Sustained Drug Delivery and Proliferation Inhibition of Breast Cancer Cells
  396. Smart Porous Silicon Nanoparticles with Polymeric Coatings for Sequential Combination Therapy
  397. Multimodal non-linear optical imaging for the investigation of drug nano-/microcrystal–cell interactions
  398. Microfluidic Assembly of a Multifunctional Tailorable Composite System Designed for Site Specific Combined Oral Delivery of Peptide Drugs
  399. Simple Microfluidic Approach to Fabricate Monodisperse Hollow Microparticles for Multidrug Delivery
  400. Controlled Dissolution of Griseofulvin Solid Dispersions from Electrosprayed Enteric Polymer Micromatrix Particles: Physicochemical Characterization and in Vitro Evaluation
  401. Systematic in vitro and in vivo study on porous silicon to improve the oral bioavailability of celecoxib
  402. Diatomite nanoparticles as potential drug delivery systems
  403. Inhibition of Multidrug Resistance of Cancer Cells by Co-Delivery of DNA Nanostructures and Drugs Using Porous Silicon Nanoparticles@Giant Liposomes
  404. Microfluidics: A Versatile and Robust Microfluidic Platform Toward High Throughput Synthesis of Homogeneous Nanoparticles with Tunable Properties (Adv. Mater. 14/2015)
  405. Multifunctional porous silicon nanoparticles for cancer theranostics
  406. Dual-drug delivery by porous silicon nanoparticles for improved cellular uptake, sustained release, and combination therapy
  407. Drug Delivery: On-Chip Self-Assembly of a Smart Hybrid Nanocomposite for Antitumoral Applications (Adv. Funct. Mater. 10/2015)
  408. A Versatile and Robust Microfluidic Platform Toward High Throughput Synthesis of Homogeneous Nanoparticles with Tunable Properties
  409. Improved stability and biocompatibility of nanostructured silicon drug carrier for intravenous administration
  410. 3.5 Current Trends and Developments for Nanotechnology in Cancer
  411. On-Chip Self-Assembly of a Smart Hybrid Nanocomposite for Antitumoral Applications
  412. Functionalization of Alkyne-Terminated Thermally Hydrocarbonized Porous Silicon Nanoparticles With Targeting Peptides and Antifouling Polymers: Effect on the Human Plasma Protein Adsorption
  413. Mesoporous Biomaterials – multifunctional materials for future medical therapies and bioanalysis
  414. Surface bioengineering of diatomite based nanovectors for efficient intracellular uptake and drug delivery
  415. Microfluidic assisted one-step fabrication of porous silicon@acetalated dextran nanocomposites for precisely controlled combination chemotherapy
  416. Solid state transformations in consequence of electrospraying – A novel polymorphic form of piroxicam
  417. Safety and toxicity concerns of orally delivered nanoparticles as drug carriers
  418. A prospective cancer chemo-immunotherapy approach mediated by synergistic CD326 targeted porous silicon nanovectors
  419. Revolutionary impact of nanovaccines on immunotherapy
  420. Coherent anti-Stokes Raman scattering microscopy driving the future of loaded mesoporous silica imaging
  421. In vitro assessment of biopolymer-modified porous silicon microparticles for wound healing applications
  422. Surface chemistry dependent immunostimulative potential of porous silicon nanoplatforms
  423. The impact of nanoparticles on the mucosal translocation and transport of GLP-1 across the intestinal epithelium
  424. Antihyperglycemic Potential of Incretins Orally Delivered via Nano and Microsystems and Subsequent Glucoregulatory Effects
  425. Targeting Membrane Transporters and Receptors as a mean to Optimize Orally Delivered Biotechnological based Drugs through Nanoparticle Delivery Systems
  426. In vivo biocompatibility of porous silicon biomaterials for drug delivery to the heart
  427. Microfluidics-assisted engineering of polymeric microcapsules with high encapsulation efficiency for protein drug delivery
  428. Augmented cellular trafficking and endosomal escape of porous silicon nanoparticles via zwitterionic bilayer polymer surface engineering
  429. Chitosan-modified porous silicon microparticles for enhanced permeability of insulin across intestinal cell monolayers
  430. In Vivo Evaluation of Porous Silicon and Porous Silicon Solid Lipid Nanocomposites for Passive Targeting and Imaging
  431. Gene-based therapy for Type 1 diabetes mellitus: viral and nonviral vectors
  432. Fabrication of a Multifunctional Nano-in-micro Drug Delivery Platform by Microfluidic Templated Encapsulation of Porous Silicon in Polymer Matrix
  433. Conjugation of Peptides to Antisense Interleukin-6 Via Click Chemistry
  434. Porous silicon nanoparticles for nanomedicine: preparation and biomedical applications
  435. Microfluidic Assembly of Monodisperse Multistage pH-Responsive Polymer/Porous Silicon Composites for Precisely Controlled Multi-Drug Delivery
  436. Confinement Effects on Drugs in Thermally Hydrocarbonized Porous Silicon
  437. Poly(methyl vinyl ether-alt-maleic acid)-Functionalized Porous Silicon Nanoparticles for Enhanced Stability and Cellular Internalization
  438. Mesoporous Materials and Nanocrystals for Enhancing the Dissolution Behavior of Poorly Water-soluble Drugs
  439. Microfluidic assembly of multistage porous silicon–lipid vesicles for controlled drug release
  440. Amine-modified hyaluronic acid-functionalized porous silicon nanoparticles for targeting breast cancer tumors
  441. Biocompatibility of porous silicon for biomedical applications
  442. Copper-free azide–alkyne cycloaddition of targeting peptides to porous silicon nanoparticles for intracellular drug uptake
  443. Preface
  444. Diatom silica microparticles for sustained release and permeation enhancement following oral delivery of prednisone and mesalamine
  445. Tumour homing peptide-functionalized porous silicon nanovectors for cancer therapy
  446. Microfluidic Templated Mesoporous Silicon–Solid Lipid Microcomposites for Sustained Drug Delivery
  447. The mechanisms of surface chemistry effects of mesoporous silicon nanoparticles on immunotoxicity and biocompatibility
  448. Co-delivery of a hydrophobic small molecule and a hydrophilic peptide by porous silicon nanoparticles
  449. Inhibition of Influenza A Virus Infection in Vitro by Saliphenylhalamide-Loaded Porous Silicon Nanoparticles
  450. Drug delivery with nanostructured porous silicon nanoparticles
  451. Nanostructured Silicon-Based Materials as a Drug Delivery System for Water-Insoluble Drugs
  452. Metabolism of the Antituberculosis Drug Ethionamide
  453. Porous Silicon Nanoparticles
  454. Evaluation of the Physicochemical and Biopharmaceutical Properties of Fluoro-Indomethacin
  455. Editorial (Hot Topic: Non-Animal Models Used in Drug Discovery: Drug Absorption and Metabolism)
  456. Improving Oral Absorption Via Drug-Loaded Nanocarriers: Absorption Mechanisms, Intestinal Models and Rational Fabrication
  457. Encyclopedia of Metalloproteins
  458. Nanostructured Porous Silicon-Solid Lipid Nanocomposite: Towards Enhanced Cytocompatibility and Stability, Reduced Cellular Association, and Prolonged Drug Release
  459. Oral Delivery of Glucagon-like Peptide-1 and Analogs: Alternatives for Diabetes Control?
  460. A new cocrystal and salts of itraconazole: Comparison of solid-state properties, stability and dissolution behavior
  461. Nanostructured porous Si-based nanoparticles for targeted drug delivery
  462. Porous-based biomaterials for tissue engineering and drug delivery applications
  463. Amine Modification of Thermally Carbonized Porous Silicon with Silane Coupling Chemistry
  464. Toxicological Profile of Therapeutic Nanodelivery Systems
  465. Nanostructured porous silicon materials: potential candidates for improving drug delivery
  466. Nanostructured porous silicon in preclinical imaging: Moving from bench to bedside
  467. New times, new trends for ethionamide: In vitro evaluation of drug-loaded thermally carbonized porous silicon microparticles
  468. The mucoadhesive and gastroretentive properties of hydrophobin-coated porous silicon nanoparticle oral drug delivery systems
  469. Intravenous Delivery of Hydrophobin-Functionalized Porous Silicon Nanoparticles: Stability, Plasma Protein Adsorption and Biodistribution
  470. Nanoparticulate targeted drug delivery using peptides and proteins
  471. Cellular interactions of surface modified nanoporous silicon particles
  472. Tablet preformulations of indomethacin-loaded mesoporous silicon microparticles
  473. Functional hydrophobin-coating of thermally hydrocarbonized porous silicon microparticles
  474. 18F-Labeled Modified Porous Silicon Particles for Investigation of Drug Delivery Carrier Distribution in Vivo with Positron Emission Tomography
  475. Editorial [Hot Topic: Innovative Technologies for Drug Delivery Applications: From Biopolymers and Nanocapsules to Inorganic Materials (Guest Editor: Helder A. Santos)]
  476. Multifunctional Porous Silicon for Therapeutic Drug Delivery and Imaging
  477. 4th BBBB International Conference on Pharmaceutical Sciences
  478. Poster Presentation
  479. Drug Delivery Formulations of Ordered and Nonordered Mesoporous Silica: Comparison of Three Drug Loading Methods
  480. Comparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazole
  481. Physicochemical stability of high indomethacin payload ordered mesoporous silica MCM-41 and SBA-15 microparticles
  482. Drug permeation across intestinal epithelial cells using porous silicon nanoparticles
  483. Mesoporous materials as controlled drug delivery formulations
  484. In vitro cytotoxicity of porous silicon microparticles: Effect of the particle concentration, surface chemistry and size
  485. Long time effect on the stability of silver nanoparticles in aqueous medium: Effect of the synthesis and storage conditions
  486. Biocompatibility of Thermally Hydrocarbonized Porous Silicon Nanoparticles and their Biodistribution in Rats
  487. Cytotoxicity study of ordered mesoporous silica MCM-41 and SBA-15 microparticles on Caco-2 cells
  488. Electrochemical Properties of Phospholipid Monolayers at Liquid–Liquid Interfaces
  489. Biocompatibility of mesoporous silicon microparticles
  490. Drug dissolution studies on mesoporous silicon particles—A theoretical approach
  491. Failure of MTT as a Toxicity Testing Agent for Mesoporous Silicon Microparticles
  492. Thermodynamic analysis of binding between drugs and glycosaminoglycans by isothermal titration calorimetry and fluorescence spectroscopy
  493. Adsorption–Penetration Studies of Glucose Oxidase into Phospholipid Monolayers at the 1,2-Dichloroethane/Water Interface
  494. Cover Picture: Effect of Gramicidin on Phospholipid-Modified Monolayers and on Ion Transfer at a Liquid–Liquid Interface (ChemPhysChem 6/2007)
  495. Effect of Gramicidin on Phospholipid-Modified Monolayers and on Ion Transfer at a Liquid–Liquid Interface
  496. Analysis of adsorption of phospholipids at the 1,2-dichloroethane/water interface by electrochemical impedance spectroscopy: A study of the effect of the saturated alkyl chain
  497. Preparation of nanostructures composed of dextran sulfate/ruthenium nanoparticles and their interaction with phospholipid monolayers at a liquid–liquid interface
  498. Electrochemical Study of Interfacial Composite Nanostructures:  Polyelectrolyte/Gold Nanoparticle Multilayers Assembled on Phospholipid/Dextran Sulfate Monolayers at a Liquid−Liquid Interface
  499. Interfacial Interaction between Dextran Sulfate and Lipid Monolayers:  An Electrochemical Study†
  500. CHAPTER 9. Diatoms: A Natural Source of Nanostructured Silica for Drug Delivery